Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024491
Filing Date
2022-11-10
Accepted
2022-11-10 16:18:55
Documents
95
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q thrn-20220930.htm   iXBRL 10-Q 5180107
2 EX-31.1 thrn-ex31_1.htm EX-31.1 22266
3 EX-31.2 thrn-ex31_2.htm EX-31.2 22353
4 EX-32.1 thrn-ex32_1.htm EX-32.1 15797
5 EX-32.2 thrn-ex32_2.htm EX-32.2 16699
  Complete submission text file 0000950170-22-024491.txt   18599682

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrn-20220930_pre.xml EX-101.PRE 685011
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrn-20220930_def.xml EX-101.DEF 541177
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrn-20220930.xsd EX-101.SCH 118603
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrn-20220930_cal.xml EX-101.CAL 91925
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT thrn-20220930_lab.xml EX-101.LAB 886027
89 EXTRACTED XBRL INSTANCE DOCUMENT thrn-20220930_htm.xml XML 3859643
Mailing Address 620 OMNI INDUSTRIAL BLVD. SUMMERVILLE SC 29483
Business Address 620 OMNI INDUSTRIAL BLVD. SUMMERVILLE SC 29483 843-501-0286
Thorne Healthtech, Inc. (Filer) CIK: 0001844280 (see all company filings)

EIN.: 272877253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40826 | Film No.: 221377515
SIC: 2834 Pharmaceutical Preparations